Desai Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 5.55 Cr
as on 24-12-2024
- Paid Up Capital ₹ 5.55 Cr
as on 24-12-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.75 Cr
as on 24-12-2024
- Satisfied Charges ₹ 6.20 Cr
as on 24-12-2024
- Revenue 42.29%
(FY 2022)
- Profit 59.04%
(FY 2022)
- Ebitda 760.81%
(FY 2022)
- Net Worth -11.61%
(FY 2022)
- Total Assets 38.09%
(FY 2022)
About Desai Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.55 Cr and a paid-up capital of Rs 5.55 Cr.
The company currently has active open charges totaling ₹16.75 Cr. The company has closed loans amounting to ₹6.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Suryawanshi, Praveen Mishra, and Chandrashekhar Maskare serve as directors at the Company.
- CIN/LLPIN
U74999MH2013PTC247908
- Company No.
247908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2013
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Desai Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Suryawanshi  | Director | 12-Jun-2019 | Current |
| Praveen Mishra | Director | 11-Sep-2024 | Current |
| Chandrashekhar Maskare | Whole-Time Director | 24-Mar-2021 | Current |
Financial Performance of Desai Pharma Distributors.
Desai Pharma Distributors Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.29% increase. The company also saw a substantial improvement in profitability, with a 59.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Desai Pharma Distributors?
In 2022, Desai Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Dec 2020 | ₹1.75 Cr | Open |
Hdfc Bank Limited Creation Date: 07 Jul 2017 | ₹15.00 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 14 Oct 2013 | ₹6.20 Cr | Satisfied |
How Many Employees Work at Desai Pharma Distributors?
Desai Pharma Distributors has a workforce of 60 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Desai Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Desai Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
